Universal Display Corporation

Janssen Pharmaceutica Nv

Ortho-mcneil Pharmaceutical Corp.

Universal Display Corpration

Alan Deangelis

Chuanjun Xia

Bin Ma

Vadim Adamovich

Bert Alleyne

Nasrin Ansari

Edward Barron

Walter H Yeager

James J Fiordeliso

Michael Stewart Weaver

Mingjuan Su

Zhiqiang Ji

Jui-Yi Tsai

Zeinab M Elshenawy

Gee-Hong Kuo

Dinesh Rayabarapu

Alexey Borisovich Dyatkin

Raymond Kwong

Lichang Zeng

Aihua Wang

Gregg Kottas

Keith T Demarest

Pierre-Luc T Boudreault

Chun Lin

Harvey Wendt

Rui Zhang

Patricia Pelton

Julia J Brown

Scott A Beers

Ting-Chih Wang

Eric A Margulies

David Zenan Li

Suman Layek

Kwang-Ohk Cheon

Michael Stuart Weaver

Jerald Feldman

Peter J Connolly

Stuart Emanuel

Catherine P Prouty

Steve Middleton

Jason Brooks

Bruce E Maryanoff

William V Murray

Han-Cheng Zhang

Wei-Chun Shih

Yan Zhang

Kimberly White

Linda K Jolliffe

Bruce Ray Conway

Lan Shen

Chandra R Shah

Raymond C Kwong

Stuart L Emanuel

Steve A Middleton

A compound of Formula I is disclosed where R, R, R, and Reach independently represent mono to a maximum possible number of substitutions, or no substitution; where two of Xto Xare carbon, and the other two are nitrogen; where L is an organic linker; where R, R, R, R, and Rare each independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; where Rdoes not comprise a dibenzothiophene group; and where any adjacent substituents are optionally joined or fused into a ring.

Organic host materials for electroluminescent devices

A compound comprising a heteroleptic iridium complex having a structure of Formula II, is provided. In Formula II, each of R, R, R, R, R, and R, is independently selected from the group consisting of hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl; at least one of R, R, R, R, R, and Ris not hydrogen or deuterium; and each R and R' is independently selected from a variety of substitutions. OLEDs and formulations containing the compound of Formula II are also provided.

Organic electroluminescent materials and devices

Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. Alkyl substitution at specific positions on the ligands gives rise to compounds with improved OLED properties, including saturated green emission.

Heteroleptic iridium complexes as dopants

A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L, L, and Lare each independently a direct bond, BR, NR, PR, O, S, Se, C═O, S═O, SO, SiRR', GeRR′, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NR, O, S, and Se; Xand Xeach independently carbon or nitrogen; and one of Q, Q, and Qis oxygen, and the remaining two of Q, Q, and Qeach represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.

A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent Rat one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in Rwhere that atom is the farthest away from the metal among the atoms in R; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R, the first distance is longer than the radius r by at least 2.9 Å.

A compound of: is disclosed. In Formula III, ring B and ring C are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; A-B represents a bonded pair of carbocyclic or heterocyclic rings coordinated to a metal M via a nitrogen atom in ring A and an sphybridized atom in ring B; A-C represents a bonded pair of carbocyclic or heterocyclic rings; M is a metal having an atomic number greater than 40; L' is a monoanionic bidentate ligand; m is the oxidation state of the metal M; and n is at least 1.

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

A compound having the formula Ir(L)(L)is disclosed wherein Lis an aza-DBF ligand and Lis an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein each of Ato Acomprise carbon or nitrogen; wherein at least one of Ato Ais nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R' and R″ each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R′, R″, R, R, R, R, R, and Rare optionally linked together to form a ring; wherein R, R, R′, and R″ are each independently selected from a variety of substituents; wherein R, R, R, and Rare each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; wherein n is an integer from 1 to 3; and wherein total number of carbons in at least one of the pairs Rand R, and Rand Ris at least four.

A compound including a first ligand Lof Formula I is disclosed. The compound is useful as an emitter in phosphorescent OLEDs.

Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a cycloalkyl containing group at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.

A compound useful as a host material in an OLED is provided. The compound includes at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene; wherein the compound is substituted by at least one R selected from the group consisting of alkyl, cycloalkyl, spiroalkyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combination thereof.

A compound having a structure of formula Ir(L)(L), where ligand Lhas Formula I and ligand Lhas Formula II that is useful as an emitter in OLEDs is disclosed.

A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent Rat one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in Rwhere that atom is the farthest away from the metal among the atoms in R; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R, the first distance is longer than the radius r by at least 2.9 &#x212b;.

A compound having a Pt tetradentate structure of Formula 1, is provided. In the structure of Formula 1, rings C and D each independently represent 5- or 6-membered carbocyclic or heterocyclic ring; L, L, and Lare each independently a direct bond, BR, NR, PR, O, S, Se, C&#x2550;O, S&#x2550;O, SO, SiRR', GeRR&#x2032;, alkyl, cycloalkyl, or a combination thereof; the sum of n1 and n2 is 1 or 2; X is selected from NR, O, S, and Se; Xand Xeach independently carbon or nitrogen; and one of Q, Q, and Qis oxygen, and the remaining two of Q, Q, and Qeach represents a direct bond. Formulations and devices, such as an OLEDs, that include the compound of Formula 1 are also described.

Growing community of inventors

Pennington, NJ, United States of America

Alan Deangelis